Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) Operating Margin (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Operating Margin data on record, last reported at 241.67% in Q3 2025.

  • For Q3 2025, Operating Margin fell 27829.0% year-over-year to 241.67%; the TTM value through Sep 2025 reached 3.71%, changed N/A, while the annual FY2025 figure was 5.56%, 6792.0% up from the prior year.
  • Operating Margin reached 241.67% in Q3 2025 per CAI's latest filing, down from 9.92% in the prior quarter.
  • Across five years, Operating Margin topped out at 490.06% in Q2 2024 and bottomed at 241.67% in Q3 2025.